We have been supporting the pharmaceutical and biopharmaceutical industries with drug development for over 30 years, assisting our clients in developing and bringing new drugs to market while improving the lives of their patients across the world.
The Dishman Group was founded in 1983 by Janmejay R. Vyas, Chairman of the Dishman Group. Since its inception, the Dishman Group's focus has been on the research and development of various in-house technologies to manufacture quaternary ammonium compounds (quats) and active pharmaceutical ingredients.
The Dishman Group's first facility was built in 1987 in Naroda; in 1996, the company initiated its expansion at Bavla, its current headquarters. Through several acquisitions, the Dishman Group spread its reach across the globe with multiple manufacturing facilities in India, Europe, and China-serving pharmaceutical and biopharmaceutical companies.
“I saw the need for a company that could provide high-quality, high-value products and services and be a good, reliable partner to pharmaceutical companies worldwide. Having a competitive cost-base and efficient operations is important, but what’s really key is the quality of our people, the service they provide, and the value they offer to our pharmaceutical customers.”
Janmejay R. Vyas
Since then, with the acquisition of Carbogen Amcis AG in 2006 and its vitamin and cholesterol business in 2007, Dishman Carbogen Amcis Ltd has become a global force in innovative product and service and development. Staying true to our founding principles, the business continues to advance with energetic leadership and an unparalleled focus on innovation, with the driving ambition of improving the lives of humankind.